Sotera Health Company (NASDAQ:SHC) Q2 2022 Earnings Conference Call August 4, 2022 9:00 AM ET
Company Participants
Joe Vitale - VP, IR
Michael Petras - Chairman and CEO
Michael Biehl - Interim CFO
Conference Call Participants
Lizzie Speyer - Citi
Casey Woodring - JPMorgan
Michael Polark - Wolfe Research
Matthew Mishan - KeyBanc
Ben Flox - Jefferies
Luke Sergott - Barclays
Thomas Kelliher - RBC Capital Markets
Operator
Good morning. My name is Howard and I will be your conference call operator today. At this time, I would like to welcome everyone to the Sotera Health Second Quarter 2022 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]
I will now hand the call over to the Vice President of Investor Relations, Joe Vitale.
Joe Vitale
Good morning and thank you. Welcome to Sotera Health's second quarter 2022 results call. You can find today's press release and accompanying supplemental slides in the Investors section of our website at soterahealth.com. This webcast is being recorded, and a replay will be available in the Investor Relations section of the Sotera Health website.
On the call with me today are Michael Petras, Chairman and Chief Executive Officer; and Michael Biehl, Interim Chief Financial Officer. During the call, some of the statements the company makes may be considered forward-looking statements.
The matters addressed in these statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to Sotera Health's SEC filings and the forward-looking statement slide at the beginning of our presentation for a description of these risks and uncertainties. The company assumes no obligation to update any such forward-looking statements.
Please note that during the discussion today, the company will present both GAAP and non-GAAP financial measures, including adjusted EBITDA, adjusted EPS and net leverage ratio. A reconciliation of non-GAAP to GAAP measures for all relevant periods may be found in the schedules attached to the company's press release and in our supplemental slides.
The operator will be assisting with the Q&A portion of the call today. Please limit yourself to one question and one follow-up so that we can try to give everyone an opportunity to ask questions.
I'll now turn the call over to Sotera Health Chairman and CEO, Michael Petras.
Michael Petras